GetNews Press Release.The global mRNA synthesis and manufacturing market is projected to grow from USD 624.4 million in 2024 to USD 738.3 million by 2029, at a CAGR of 3.4%. Key drivers include ...

These trends, along with intensified global efforts in product development, are driving innovation, expanding manufacturing capacity, and strengthening the global mRNA synthesis and production market.

During protein synthesis, or translation, genetic information transcribed in the cell's mRNA directs the stringing together ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

Combining AI-driven design with rapid, cell-free DNA synthesis, researchers are turning mRNA into a scalable solution for vaccines, cancer treatments, and personalized genetic therapies.

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and formulation capabilities with the launch of a GMP-like mRNA manufacturing ...

Unlocking the potential of mRNA technology is helping revolutionize medicine and biotechnology. Solid-phase in vitro transcription enables scalability and automation, helping make it a valuable tool ...

Giving scientists direct control over DNA and mRNA synthesis timelines is a game changer, enabling high-fidelity genes and mRNA constructs to be built overnight, on demand, and right in the lab.

The mRNA synthesis and manufacturing market has witnessed significant growth over the past few years, propelled by the success of mRNA-based COVID-19 vaccines .

Its adaptability makes mRNA a cornerstone of personalized medicine, enabling the customization of treatments to suit individual patients. These trends, along with intensified global efforts in product ...